Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia
Autor(a) principal: | |
---|---|
Data de Publicação: | 2008 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/21550 |
Resumo: | Background The present study sought to investigate the correlation of copeptin with the severity of septic status in patients with ventilator-associated pneumonia (VAP), and to analyze the usefulness of copeptin as a predictor of mortality in VAP. Methods The prospective observational cohort study was conducted in a teaching hospital. The subjects were 71 patients consecutively admitted to the intensive care unit from October 2003 to August 2005 who developed VAP. Copeptin levels were determined on day 0 and day 4 of VAP. Patients were followed for 28 days after the diagnosis, when they were considered survivors. Patients who died before day 28 were classified as nonsurvivors. There were no interventions. Results Copeptin levels increased from sepsis to severe sepsis and septic shock both on day 0 and day 4 (P = 0.001 and P = 0.009, respectively). Variables included in the univariable logistic regression analysis for mortality were age, gender, Acute Physiology and Chronic Health Evaluation II score and ln copeptin on day 0 and day 4. Mortality was directly related to ln copeptin levels on day 0 and day 4, with odds ratios of 2.32 (95% confidence interval, 1.25 to 4.29) and 2.31 (95% confidence interval, 1.25 to 4.25), respectively. In a multivariable logistic regression model for mortality, only ln copeptin on day 0 with odds ratio 1.97 (95% confidence interval, 1.06 to 3.69) and ln copeptin on day 4 with odds ratio 2.39 (95% confidence interval, 1.24 to 4.62) remained significant. Conclusion Our data demonstrate that copeptin levels increase progressively with the severity of sepsis and are independent predictors of mortality in VAP. |
id |
UFRGS-2_a3156792c9c053d681c4795a0e4b653c |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/21550 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Seligman, RenatoPapassotiriou, JanaMorgenthaler, Nils G.Meisner, MichaelTeixeira, Paulo Jose Zimermann2010-05-05T04:15:50Z20081364-8535http://hdl.handle.net/10183/21550000655073Background The present study sought to investigate the correlation of copeptin with the severity of septic status in patients with ventilator-associated pneumonia (VAP), and to analyze the usefulness of copeptin as a predictor of mortality in VAP. Methods The prospective observational cohort study was conducted in a teaching hospital. The subjects were 71 patients consecutively admitted to the intensive care unit from October 2003 to August 2005 who developed VAP. Copeptin levels were determined on day 0 and day 4 of VAP. Patients were followed for 28 days after the diagnosis, when they were considered survivors. Patients who died before day 28 were classified as nonsurvivors. There were no interventions. Results Copeptin levels increased from sepsis to severe sepsis and septic shock both on day 0 and day 4 (P = 0.001 and P = 0.009, respectively). Variables included in the univariable logistic regression analysis for mortality were age, gender, Acute Physiology and Chronic Health Evaluation II score and ln copeptin on day 0 and day 4. Mortality was directly related to ln copeptin levels on day 0 and day 4, with odds ratios of 2.32 (95% confidence interval, 1.25 to 4.29) and 2.31 (95% confidence interval, 1.25 to 4.25), respectively. In a multivariable logistic regression model for mortality, only ln copeptin on day 0 with odds ratio 1.97 (95% confidence interval, 1.06 to 3.69) and ln copeptin on day 4 with odds ratio 2.39 (95% confidence interval, 1.24 to 4.62) remained significant. Conclusion Our data demonstrate that copeptin levels increase progressively with the severity of sepsis and are independent predictors of mortality in VAP.application/pdfengCritical Care. London : Current Science, 2008. Vol. 12, n.1 (Feb. 2008), R11Pneumonia associada à ventilação mecânicaCopeptin, a novel prognostic biomarker in ventilator-associated pneumoniaEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSORIGINAL000655073.pdf000655073.pdfTexto completoapplication/pdf337390http://www.lume.ufrgs.br/bitstream/10183/21550/1/000655073.pdf2f07056ea0a3a294147e15824032fa2eMD51TEXT000655073.pdf.txt000655073.pdf.txtExtracted Texttext/plain33573http://www.lume.ufrgs.br/bitstream/10183/21550/2/000655073.pdf.txt59a3dd37b0b69a8578c94c305e8ed3a1MD52THUMBNAIL000655073.pdf.jpg000655073.pdf.jpgGenerated Thumbnailimage/jpeg2144http://www.lume.ufrgs.br/bitstream/10183/21550/3/000655073.pdf.jpgdafdcf329ac8ab728841c02394257d75MD5310183/215502018-10-17 09:40:20.167oai:www.lume.ufrgs.br:10183/21550Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2018-10-17T12:40:20Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia |
title |
Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia |
spellingShingle |
Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia Seligman, Renato Pneumonia associada à ventilação mecânica |
title_short |
Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia |
title_full |
Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia |
title_fullStr |
Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia |
title_full_unstemmed |
Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia |
title_sort |
Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia |
author |
Seligman, Renato |
author_facet |
Seligman, Renato Papassotiriou, Jana Morgenthaler, Nils G. Meisner, Michael Teixeira, Paulo Jose Zimermann |
author_role |
author |
author2 |
Papassotiriou, Jana Morgenthaler, Nils G. Meisner, Michael Teixeira, Paulo Jose Zimermann |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Seligman, Renato Papassotiriou, Jana Morgenthaler, Nils G. Meisner, Michael Teixeira, Paulo Jose Zimermann |
dc.subject.por.fl_str_mv |
Pneumonia associada à ventilação mecânica |
topic |
Pneumonia associada à ventilação mecânica |
description |
Background The present study sought to investigate the correlation of copeptin with the severity of septic status in patients with ventilator-associated pneumonia (VAP), and to analyze the usefulness of copeptin as a predictor of mortality in VAP. Methods The prospective observational cohort study was conducted in a teaching hospital. The subjects were 71 patients consecutively admitted to the intensive care unit from October 2003 to August 2005 who developed VAP. Copeptin levels were determined on day 0 and day 4 of VAP. Patients were followed for 28 days after the diagnosis, when they were considered survivors. Patients who died before day 28 were classified as nonsurvivors. There were no interventions. Results Copeptin levels increased from sepsis to severe sepsis and septic shock both on day 0 and day 4 (P = 0.001 and P = 0.009, respectively). Variables included in the univariable logistic regression analysis for mortality were age, gender, Acute Physiology and Chronic Health Evaluation II score and ln copeptin on day 0 and day 4. Mortality was directly related to ln copeptin levels on day 0 and day 4, with odds ratios of 2.32 (95% confidence interval, 1.25 to 4.29) and 2.31 (95% confidence interval, 1.25 to 4.25), respectively. In a multivariable logistic regression model for mortality, only ln copeptin on day 0 with odds ratio 1.97 (95% confidence interval, 1.06 to 3.69) and ln copeptin on day 4 with odds ratio 2.39 (95% confidence interval, 1.24 to 4.62) remained significant. Conclusion Our data demonstrate that copeptin levels increase progressively with the severity of sepsis and are independent predictors of mortality in VAP. |
publishDate |
2008 |
dc.date.issued.fl_str_mv |
2008 |
dc.date.accessioned.fl_str_mv |
2010-05-05T04:15:50Z |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/21550 |
dc.identifier.issn.pt_BR.fl_str_mv |
1364-8535 |
dc.identifier.nrb.pt_BR.fl_str_mv |
000655073 |
identifier_str_mv |
1364-8535 000655073 |
url |
http://hdl.handle.net/10183/21550 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Critical Care. London : Current Science, 2008. Vol. 12, n.1 (Feb. 2008), R11 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/21550/1/000655073.pdf http://www.lume.ufrgs.br/bitstream/10183/21550/2/000655073.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/21550/3/000655073.pdf.jpg |
bitstream.checksum.fl_str_mv |
2f07056ea0a3a294147e15824032fa2e 59a3dd37b0b69a8578c94c305e8ed3a1 dafdcf329ac8ab728841c02394257d75 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1815447408771858432 |